Bios Partners
Finance · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1751 River Run Ste 400, Fort Worth, Texa...Phone Number
(817) 345-6844Website
www.biospartners.comRevenue
<$5 MillionIndustry
About Bios Partners
Bios Partners Org Chart
Is Bios Partners your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Bios Partners, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Bios Partners is spiking on competitors!
Product Launch: Get notified when Bios Partners launches new products
Congratulate Masked Content for being promoted to Masked Content at Bios Partners
Website visits: Recent activity has been detected on your website
Check if Bios Partners has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Bios Partners has new funding data
Earning: See what the market has to say on Bios Partners recently announced quarterly report
Click to see if Bios Partners had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Bios Partners
Find 3 more new buyers
Compare Similar Companies to Bios Partners
Compare insights from companies similar to Bios Partners, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bios Partners is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Bios Partners is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Bios Partners.
Bios Partners Tech Stack
A closer look at the technologies used by Bios Partners
Most Recent Scoops
Bios Partners News & Media
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three ...
Beyond retinal detachment, lead candidate ONL1204 will also advance into the chronic conditions of glaucoma and dry age-related macular degeneration over the next 24 monthsActuate Therapeutics Completes $6.5M Series B-3
FORT WORTH, TX, Actuate Therapeutics, a clinical stage biopharmaceutical company, today announced it has raised an additional $6.5M in a Series B-3 financing round.Actuate Therapeutics Inc. Completes $6.5 Million Series B-3 Financing
Company Will Use Proceeds To Expand Clinical Programs (PRWeb November 12, 2019) Read the full story at https://www.prweb.com/releases/actuate_therapeutics_inc_completes_6_5_million_series_b_3_financing/prweb16709064.htmActuate Therapeutics Inc. Completes $6.5 Million Series B-3 Financing
Venture capital news. Updated daily. VC deal news, fund news, transition news, industry news.
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bios Partners
Bios Partners is a venture capital firm focused on identifying and bringing advanced biotech innovations to market in the U.S. They aim to disrupt geographic favoritism in venture capital by investing in compelling scientific opportunities across the Central U.S. that are often overlooked. Their portfolio includes clinical-stage companies developin... Read More